Temporal molecular program of human hematopoietic stem and progenitor cells after birth

Dev Cell. 2022 Dec 19;57(24):2745-2760.e6. doi: 10.1016/j.devcel.2022.11.013. Epub 2022 Dec 8.

Abstract

Hematopoietic stem and progenitor cells (HSPCs) give rise to the blood system and maintain hematopoiesis throughout the human lifespan. Here, we report a transcriptional census of human bone-marrow-derived HSPCs from the neonate, infant, child, adult, and aging stages, showing two subpopulations of multipotent progenitors separated by CD52 expression. From birth to the adult stage, stem and multipotent progenitors shared similar transcriptional alterations, and erythroid potential was enhanced after the infant stage. By integrating transcriptome, chromatin accessibility, and functional data, we further showed that aging hematopoietic stem cells (HSCs) exhibited a bias toward megakaryocytic differentiation. Finally, in comparison with the HSCs from the cord blood, neonate bone-marrow-derived HSCs were more quiescent and had higher long-term regeneration capability and durable self-renewal. Taken together, this work provides an integral transcriptome landscape of HSPCs and identifies their dynamics in post-natal steady-state hemopoiesis, thereby helping explore hematopoiesis in development and diseases.

Keywords: hematopoietic stem and progenitor cells; human hematopoiesis; post-natal development; single-cell RNA-seq.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cell Differentiation
  • Child
  • Hematopoiesis*
  • Hematopoietic Stem Cells* / metabolism
  • Humans
  • Infant
  • Infant, Newborn